Depletion of Preβ 1 LpA1 and LpA4 Particles by Mast Cell Chymase Reduces Cholesterol Efflux From Macrophage Foam Cells Induced by Plasma
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (4) , 1066-1074
- https://doi.org/10.1161/01.atv.19.4.1066
Abstract
—Exposure of the LpA1-containing particles present in HDL 3 and plasma to a minimal degree of proteolysis by the neutral protease chymase from exocytosed rat mast cell granules (granule remnants) leads to a reduction in the high-affinity component of cholesterol efflux from macrophage foam cells. In this study, we demonstrate for the first time, a role for mast cell chymase in the depletion of the lipid-poor minor components of HDL that are specifically involved in reverse cholesterol transport as initial acceptors of cellular cholesterol. Thus, addition of proteolytically active granule remnants or human skin chymase to cholesterol-loaded macrophages of mouse or human origin incubated with human apoA1, ie, a system in which preβ 1 LpA1 is generated, resulted in a sharp reduction in the high-affinity cholesterol efflux promoted by apoA1. As determined by nondenaturing 2-dimensional polyacrylamide gradient gel electrophoresis, the granule remnants effectively depleted the preβ 1 LpA1, but not the αLpA1, in HDL 3 and in plasma during incubation at 37°C for 3 and granule remnant-treated plasma to induce cholesterol efflux from macrophage foam cells is caused by selective depletion by mast cell chymase of quantitatively minor A1- and A4-containing subpopulations of HDL. Because these particles, ie, preβ 1 LpA1 and LpA4, are efficient acceptors of cholesterol from cell surfaces, their depletion by mast cells may block the initiation of reverse cholesterol transport in vivo and thereby favor foam cell formation in the arterial intima, the site of atherogenesis.Keywords
This publication has 49 references indexed in Scilit:
- Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.Journal of Clinical Investigation, 1996
- Phospholipid transfer protein mediated conversion of high density lipoproteins generates preβ1-HDLBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.Journal of Clinical Investigation, 1996
- Pre-β HDL: structure and metabolismBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Identification of a Sequence of Apolipoprotein A-I Associated with the Efflux of Intracellular Cholesterol to Human Serum and Apolipoprotein A-I Containing ParticlesBiochemistry, 1996
- Cycling of apolipoprotein A-I between lipid-associated and lipid-free poolsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptidesBiochemistry, 1995
- Unique Epitope of Apolipoprotein A-I Expressed in Pre-.beta.-1 High-Density Lipoprotein and Its Role in the Catalyzed Efflux of Cellular CholesterolBiochemistry, 1994
- Structural domain of apolipoprotein A-I involved in its interaction with cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoproteinBiochemistry, 1988